新型自动缝合技术用于二尖瓣人工腱索植入的评估:1年结果
研究对12例接受开放或微创二尖瓣修复的患者使用新型自动膨体聚四氟乙烯(ePTFE)缝合放置装置和定制钛紧固件部署装置,随访1年。30天时二尖瓣反流无8例、微量2例、轻度2例;1年时无7例、微量2例、轻度2例、中度1例。无人工腱索失败、再手术或死亡,初步结果支持进一步临床评估。
要点
- 12例患者使用新型自动ePTFE缝合与钛紧固件装置行二尖瓣修复,随访1年。
- 1年时二尖瓣反流无7例、微量2例、轻度2例、中度1例。
- 无人工腱索失败、再手术或死亡,作者认为结果鼓励进一步临床评估。
核心结论
- 新型自动ePTFE缝合放置和钛紧固件部署装置的初步结果鼓励进一步临床评估。
研究设计与样本
- 对12例接受开放或微创二尖瓣修复的患者使用研究装置,并随访1年。
- 研究终点包括手术结局、手术时间、瓣膜修复耐久性、不良事件和死亡率。
主要发现
- 3例患者使用研究技术植入1根ePTFE人工腱索,9例患者植入2根。
- 30天时二尖瓣反流无8例、微量2例、轻度2例。
- 1年随访时二尖瓣反流无7例、微量2例、轻度2例、中度1例。
- 无人工腱索失败、再手术或死亡。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: A new automated expanded polytetrafluoroethylene (ePTFE) suture placement device and a new customized titanium fastener deployment device were clinically evaluated in open and less-invasive mitral valve repair (MVr). DESCRIPTION: Twelve patients were monitored for 1 year after undergoing MVr using the study devices. The study end points included surgical outcomes, operative times, valve repair durability, adverse events, and mortality. EVALUATION: Three patients received 1 ePTFE chord using the study technology, and 9 patients received 2 chords. Mitral regurgitation at 30 days was absent in 8 patients, trace in 2, and mild in 2. At the 1-year follow-up, mitral regurgitation was absent in 7 patients, trace in 2, mild in 2, and moderate in 1. There were no replacement chord failures, reoperations, or death. CONCLUSIONS: The initial outcomes of new automated ePTFE suture placement and titanium fastener deployment devices encourage further clinical evaluations.
引用
- Werner P, Poschner T, Gross C, et al. Evaluation of a Novel Automated Suturing Technology for Mitral Chordal Implantation: 1-Year Results. Ann Thorac Surg. 2023. PMID: 37890817. doi:10.1016/j.athoracsur.2023.10.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。